DK3760190T3 - Tabletter af pregabalin med forlænget frigivelse, fremgangsmåde til fremstilling og fremgangsmåde til anvendelse deraf - Google Patents

Tabletter af pregabalin med forlænget frigivelse, fremgangsmåde til fremstilling og fremgangsmåde til anvendelse deraf Download PDF

Info

Publication number
DK3760190T3
DK3760190T3 DK20172176.8T DK20172176T DK3760190T3 DK 3760190 T3 DK3760190 T3 DK 3760190T3 DK 20172176 T DK20172176 T DK 20172176T DK 3760190 T3 DK3760190 T3 DK 3760190T3
Authority
DK
Denmark
Prior art keywords
pregabalin
tablets
manufacture
extended release
extended
Prior art date
Application number
DK20172176.8T
Other languages
English (en)
Inventor
Zhen Mei
Amit Shah
Mayank Joshi
Raghav K Gupta
Original Assignee
Alvogen Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alvogen Inc filed Critical Alvogen Inc
Application granted granted Critical
Publication of DK3760190T3 publication Critical patent/DK3760190T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid, pantothenic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0065—Forms with gastric retention, e.g. floating on gastric juice, adhering to gastric mucosa, expanding to prevent passage through the pylorus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK20172176.8T 2019-07-03 2020-04-29 Tabletter af pregabalin med forlænget frigivelse, fremgangsmåde til fremstilling og fremgangsmåde til anvendelse deraf DK3760190T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201962870121P 2019-07-03 2019-07-03

Publications (1)

Publication Number Publication Date
DK3760190T3 true DK3760190T3 (da) 2023-09-04

Family

ID=70480166

Family Applications (1)

Application Number Title Priority Date Filing Date
DK20172176.8T DK3760190T3 (da) 2019-07-03 2020-04-29 Tabletter af pregabalin med forlænget frigivelse, fremgangsmåde til fremstilling og fremgangsmåde til anvendelse deraf

Country Status (10)

Country Link
US (1) US11974974B2 (da)
EP (1) EP3760190B1 (da)
BR (1) BR102020013422A2 (da)
DK (1) DK3760190T3 (da)
ES (1) ES2953059T3 (da)
FI (1) FI3760190T3 (da)
HU (1) HUE063492T2 (da)
PL (1) PL3760190T3 (da)
PT (1) PT3760190T (da)
RS (1) RS64394B1 (da)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN116898819B (zh) * 2023-06-09 2024-02-06 则正(上海)生物科技有限公司 一种普瑞巴林缓释剂及其制备方法

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2781793B1 (fr) * 1998-08-03 2001-07-20 Prographarm Lab Procede de fabrication de granules de gabapentine enrobes
NL2000281C2 (nl) 2005-11-02 2007-08-07 Pfizer Prod Inc Vaste farmaceutische samenstellingen die pregabaline bevatten.
EP2117517B1 (en) 2007-01-11 2011-06-01 XenoPort, Inc. Sustained release oral dosage forms of a prodrug of r-baclofen and methods of treatment
EP2440190A1 (en) 2009-06-12 2012-04-18 Micro Labs Limited Novel pharmaceutical compositions containing pregabalin
WO2010150221A1 (en) 2009-06-25 2010-12-29 Wockhardt Research Centre Taste masked pharmaceutical compositions of pregabalin
KR101317592B1 (ko) 2009-10-28 2013-10-15 씨제이제일제당 (주) 프레가발린, 폴리에틸렌옥사이드 및 폴리비닐알코올-폴리에틸렌글리콜 그라프트 공중합체를 함유하는 위체류형 서방성 제제
WO2011151708A1 (en) 2010-06-01 2011-12-08 Rubicon Research Private Limited Gastroretentive dosage forms of gaba analogs
JP6005636B2 (ja) 2010-07-06 2016-10-12 グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング Ｇａｂａ類似体及びオピオイドを含む新規胃内滞留型剤形
WO2013114281A1 (en) * 2012-01-30 2013-08-08 Ranbaxy Laboratories Limited Pregabalin gr tablets
KR101269829B1 (ko) 2012-04-27 2013-05-30 씨제이제일제당 (주) 위체류 약물전달 시스템을 이용한 서방성 제제
EP2906202A4 (en) * 2012-10-15 2016-04-27 Isa Odidi DRUG FORMULATIONS FOR ORAL ADMINISTRATION
EP2908803A1 (en) 2012-10-16 2015-08-26 Ranbaxy Laboratories Limited Osmotic floating tablets
US20160338949A1 (en) 2014-01-28 2016-11-24 Sun Pharmaceutical Industries Limited Stabilized gastroretentive tablets of pregabalin
WO2015157138A1 (en) * 2014-04-07 2015-10-15 Banner Life Sciences Llc Abuse-deterrent controlled release formulations

Also Published As

Publication number Publication date
HUE063492T2 (hu) 2024-01-28
EP3760190B1 (en) 2023-05-24
US20210000775A1 (en) 2021-01-07
BR102020013422A2 (pt) 2021-01-12
FI3760190T3 (fi) 2023-08-09
US11974974B2 (en) 2024-05-07
PL3760190T3 (pl) 2023-09-04
EP3760190A1 (en) 2021-01-06
ES2953059T3 (es) 2023-11-07
PT3760190T (pt) 2023-07-31
RS64394B1 (sr) 2023-08-31

Similar Documents

Publication Publication Date Title
DK3788044T3 (da) RIP1-hæmmende forbindelser og fremgangsmåder til fremstilling og anvendelse heraf
DK3507386T3 (da) Fremgangsmåder og indretning, der øger effektiviteten af sekvensering med binding
DK3601533T3 (da) Fremgangsmåder til frembringelse af tumorinfiltrerende lymfocytter og anvendelser af samme i immunoterapi
DK3283435T3 (da) Sammensætning, partikelformede materialer og fremgangsmåder til fremstilling af partikelformede materialer
DK3491173T3 (da) Fremgangsmåde og anlæg til fremstilling af methanol
DK3350201T3 (da) Manipulerede fytaser og fremgangsmåder til anvendelse af samme
DK3048295T3 (da) Fremgangsmåde til opførelse af en vindmølle og vindmølle
DK3517607T3 (da) Hidtil ukendt aspartokinase-mutant og fremgangsmåde til fremstilling af L-aminosyre under anvendelse af samme
DK3262008T3 (da) Partikelformede sammensætninger til dannelse af geopolymerer, deres anvendelse og fremgangsmåder til dannelse af geopolymere dermed
DK3490575T3 (da) Planteekstrakt med høj koncentration af safranal, fremstillingsfremgangsmåde og anvendelser
DK3355329T3 (da) Metode til fremstilling af lithium-ion-kondensator og kondensator som opnås med den nævnte metode
DK3259759T3 (da) Atombrændselspille og fremgangsmåde til fremstilling deraf
DK3325422T3 (da) Fremgangsmåde og indretning til fremstilling af et ekspanderet granulat
DK3606929T3 (da) Beta-nicotinat-ester-nukleotider og fremgangsmåder til fremstilling af samme
DK3672919T3 (da) Anlæg og fremgangsmåde til fremstilling af cementklinker
DK3649104T3 (da) Fremgangsmåde til fremstilling af langkædede aminosyrer og dibasiske syrer
DK3574135T3 (da) Fremgangsmåde og formulering til fremstilling af ligninfibre
DK3277742T3 (da) Fluorescerende siloxanelastomer, fremgangsmåde til fremstilling af denne og anvendelsen
DK3465202T3 (da) Massespektrometrifremgangsmåde til detektering og kvantitering af metabolitter
DK3441381T3 (da) Fremgangsmåde til fremstilling af methanol og indretning til fremstilling af methanol
DK3743359T3 (da) Fremgangsmåde til fremstilling af en drikkevare med anvendelse af en portionspakning, og portionspakning
DK3515861T3 (da) Anlæg og fremgangsmåde til fremstilling af salpetersyre
DK3452424T3 (da) Fremgangsmåde og anlæg til fremstilling af cement
DK3650821T3 (da) System og fremgangsmåde til bestemmelse af tænders farve
DK3287469T3 (da) Gluconat-repressorvariant, L-lysin-producerende mikroorganisme omfattende samme og frem-gangsmåde til fremstilling af L-lysin under anvendelse af samme